Correlation Between Lipum AB and Nobia AB
Can any of the company-specific risk be diversified away by investing in both Lipum AB and Nobia AB at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Lipum AB and Nobia AB into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Lipum AB and Nobia AB, you can compare the effects of market volatilities on Lipum AB and Nobia AB and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Lipum AB with a short position of Nobia AB. Check out your portfolio center. Please also check ongoing floating volatility patterns of Lipum AB and Nobia AB.
Diversification Opportunities for Lipum AB and Nobia AB
Very weak diversification
The 3 months correlation between Lipum and Nobia is 0.45. Overlapping area represents the amount of risk that can be diversified away by holding Lipum AB and Nobia AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Nobia AB and Lipum AB is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Lipum AB are associated (or correlated) with Nobia AB. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Nobia AB has no effect on the direction of Lipum AB i.e., Lipum AB and Nobia AB go up and down completely randomly.
Pair Corralation between Lipum AB and Nobia AB
Assuming the 90 days trading horizon Lipum AB is expected to generate 1.55 times more return on investment than Nobia AB. However, Lipum AB is 1.55 times more volatile than Nobia AB. It trades about 0.09 of its potential returns per unit of risk. Nobia AB is currently generating about -0.03 per unit of risk. If you would invest 1,200 in Lipum AB on December 30, 2024 and sell it today you would earn a total of 290.00 from holding Lipum AB or generate 24.17% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Lipum AB vs. Nobia AB
Performance |
Timeline |
Lipum AB |
Nobia AB |
Lipum AB and Nobia AB Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Lipum AB and Nobia AB
The main advantage of trading using opposite Lipum AB and Nobia AB positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Lipum AB position performs unexpectedly, Nobia AB can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nobia AB will offset losses from the drop in Nobia AB's long position.Lipum AB vs. Ascelia Pharma AB | Lipum AB vs. NextCell Pharma AB | Lipum AB vs. Annexin Pharmaceuticals AB | Lipum AB vs. AlzeCure Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
Other Complementary Tools
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |